{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:28:24Z","timestamp":1774682904063,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:p>Finnish invasive pneumococcal disease (FinIP) vaccine trial was designed to evaluate effectiveness of 10-valent pneumococcal conjugate vaccine (PHiD-CV10; GSK; Rixensart, Belgium). We conducted 2 satellite studies to evaluate ten-valent Pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) effectiveness against pneumococcal carriage in FinIP-vaccinated children (long-term direct and indirect effectiveness combined) and in their unvaccinated siblings (indirect effectiveness within the family). FinIP was a cluster randomized trial, where &gt;47,000 children &lt;19 months of age were recruited in 2009\u20132010. Children received PHiD-CV10 in 2\/3, and control vaccine in 1\/3 of clusters according to age-specific infant and catch-up schedules. We obtained nasopharyngeal samples from subgroups of FinIP-vaccinated children at 3\u20135 years of age in 2013 and their unvaccinated older siblings in 2011 and 2013, and compared carriage in PHiD-CV10 clusters to control clusters in parallel. National Vaccination Programme with PHiD-CV10 for all 3-month-old children started in 2010 resulting in 92% vaccination coverage. To investigate indirect effects, over 2200 nasopharyngeal swabs were obtained during each round from unvaccinated older siblings. In 2011, we observed a 29% (95% confidence interval: 6\u201347) reduction in vaccine-type carriage in siblings of PHiD-CV10 participants vaccinated according to infant schedules. Vaccine-type carriage prevalences were low with no differences observed in 2013, 3 years after PHiD-CV10 introduction. For estimation of combined direct and indirect effectiveness, 1550 swabs from FinIP-vaccinated children were obtained in 2013. We observed a reduction of 54% (95% confidence interval: 34\u201368) in vaccine-type carriage in PHiD-CV10\u2013vaccinated children. This study was the first randomized trial to show the indirect effect of extended valency pneumococcal conjugate vaccination on carriage. Also, long-term effectiveness against vaccine-type carriage was demonstrated in vaccinated children.<\/jats:p>","DOI":"10.1097\/inf.0000000000001705","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T22:49:35Z","timestamp":1500677375000},"page":"1193-1200","source":"Crossref","is-referenced-by-count":17,"title":["Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial"],"prefix":"10.1097","volume":"36","author":[{"given":"Arto A.","family":"Palmu","sequence":"first","affiliation":[{"name":"Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maija","family":"Toropainen","sequence":"additional","affiliation":[{"name":"Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarja","family":"Kaijalainen","sequence":"additional","affiliation":[{"name":"Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotta","family":"Siira","sequence":"additional","affiliation":[{"name":"Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Lahdenkari","sequence":"additional","affiliation":[{"name":"Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heta","family":"Nieminen","sequence":"additional","affiliation":[{"name":"Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritva K.","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[{"name":"Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terhi M.","family":"Kilpi","sequence":"additional","affiliation":[{"name":"Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Jokinen","sequence":"additional","affiliation":[{"name":"Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20231020","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease.","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"R2-20231020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/322048","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old.","volume":"184","author":"Syrj\u00e4nen","year":"2001","journal-title":"J Infect Dis"},{"key":"R3-20231020","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2008-3099","article-title":"Continued impact of pneumococcal conjugate vaccine on carriage in young children.","volume":"124","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"key":"R4-20231020","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1016\/j.vaccine.2014.03.017","article-title":"Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.","volume":"32","author":"van Hoek","year":"2014","journal-title":"Vaccine"},{"key":"R5-20231020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"key":"R6-20231020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jpids\/piw010","article-title":"Effectiveness of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-a double-blind randomized clinical trial in Finland.","volume":"5","author":"Vesikari","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R7-20231020","doi-asserted-by":"crossref","first-page":"e0120290","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children\u2013a population-based study.","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS One"},{"key":"R9-20231020","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/01.inf.0000049347.42983.77","article-title":"Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae.","volume":"22","author":"O\u2019Brien","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20231020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","article-title":"Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group.","volume":"32","author":"Satzke","year":"2013","journal-title":"Vaccine"},{"key":"R11-20231020","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1128\/JCM.41.12.5551-5556.2003","article-title":"Quantitative validation of media for transportation and storage of Streptococcus pneumoniae.","volume":"41","author":"Charalambous","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R12-20231020","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00006454-200107000-00004","article-title":"Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.","volume":"20","author":"Kilpi","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R13-20231020","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/JCM.00689-12","article-title":"From Quellung to multiplex PCR, and back when needed, in pneumococcal serotyping.","volume":"50","author":"Siira","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R14-20231020","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/IAI.71.11.6192-6198.2003","article-title":"Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides.","volume":"71","author":"van Selm","year":"2003","journal-title":"Infect Immun"},{"key":"R16-20231020","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.vaccine.2009.04.009","article-title":"Estimation of vaccine efficacy against acquisition of pneumococcal carriage.","volume":"27","author":"Rinta-Kokko","year":"2009","journal-title":"Vaccine"},{"key":"R17-20231020","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial.","volume":"196","author":"O\u2019Brien","year":"2007","journal-title":"J Infect Dis"},{"key":"R18-20231020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1086\/591966","article-title":"Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.","volume":"47","author":"Millar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R19-20231020","doi-asserted-by":"crossref","first-page":"e1001107","DOI":"10.1371\/journal.pmed.1001107","article-title":"Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.","volume":"8","author":"Roca","year":"2011","journal-title":"PLoS Med"},{"key":"R20-20231020","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1097\/MD.0000000000000335","article-title":"A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccine.","volume":"94","author":"Hamaluba","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R21-20231020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"key":"R22-20231020","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/S2214-109X(14)70224-4","article-title":"Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies.","volume":"2","author":"Hammitt","year":"2014","journal-title":"Lancet Glob Health"},{"key":"R23-20231020","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/INF.0000000000001207","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage among American Indians.","volume":"35","author":"Grant","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R24-20231020","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1016\/j.vaccine.2015.07.080","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska.","volume":"33","author":"Bruce","year":"2015","journal-title":"Vaccine"},{"key":"R25-20231020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1086\/431679","article-title":"Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.","volume":"192","author":"Dagan","year":"2005","journal-title":"J Infect Dis"},{"key":"R27-20231020","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.vaccine.2010.12.086","article-title":"Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage.","volume":"29","author":"Prymula","year":"2011","journal-title":"Vaccine"},{"key":"R28-20231020","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/cid\/cis922","article-title":"Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial.","volume":"56","author":"van den Bergh","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201712000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:14:31Z","timestamp":1697775271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201712000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001705","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}